PROVIDENCE – A sealed lawsuit was filed in Delaware District Court Monday against Immunex Rhode Island Corp. and Amgen Inc. by Genentech Inc. and City of Hope, according to court documents. The case is related to Amgen’s Mvasi and Genentech’s Avastin, both chemotherapy and targeted-therapy drugs. The U.S. Food and Drug Administration approved Mvasi (bevacizumab-awwb)…
Want More Free?
To access 2 more articles, please log in or register for free.
Registered users get access to a limited number of free articles every month.